
Vanirab Injection
Marketer
Vanshita Lifecare
Salt Composition
Rabeprazole (20mg)
Overview Vanirab Injection
AcidGard Injection is a medication that diminishes gastric acid production. It treats acid-related gastrointestinal disorders, including acid reflux, dyspepsia, peptic ulcers, and other conditions stemming from excessive stomach acid. AcidGard Injection offers rapid symptom relief and is used prophylactically against stress ulcers in critically ill patients, and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's intravenously administered by a healthcare professional only when deemed superior to oral forms by your physician. Dosage is tailored to your condition and response, with treatment duration determined by your doctor; continue as prescribed even with rapid symptom improvement. Dietary modifications, such as frequent smaller meals and avoiding caffeine, spicy, and fatty foods, can enhance treatment efficacy. Common side effects include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While usually mild, persistent or bothersome symptoms warrant medical attention. Prolonged use increases the risk of adverse effects. For example, use exceeding one year, particularly at higher doses, may raise bone fracture risk. Discuss bone health preservation strategies, such as calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low blood magnesium) has been reported in patients using AcidGard Injection for three months or longer; this can manifest as fatigue, confusion, dizziness, muscle spasms, and arrhythmias. Your physician may monitor your magnesium levels. AcidGard Injection is contraindicated for some individuals. Inform your doctor of severe hepatic impairment, concurrent HIV medication use, prior allergic reactions to similar drugs, pre-existing osteoporosis, or pregnancy/breastfeeding before use. Avoid alcohol consumption, as it exacerbates stomach acid production and symptoms. Refrain from operating machinery or driving if dizziness or drowsiness occurs.
Uses of Vanirab Injection
Management of heartburn and peptic ulcers
Major Benefits of Vanirab Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Vanirab Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Vanirab Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Vanirab Injection works:
Gastric acid secretion is diminished by Vanirab Injection, a proton pump inhibitor, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Vanirab Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Vanirab Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Vanirab Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Vanirab Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Vanirab Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Patients with advanced liver impairment should receive Vanirab Injection with close monitoring. Dosage modification for Vanirab Injection may be necessary. Physician consultation is advised.
What if you forget to take Vanirab Injection :
Omit a Vanirab Injection dose? Seek your physician's advice.
Facts to Know About Vanirab Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavior Class | Gastric acid suppressants |
